Results 211 to 220 of about 681,792 (231)

A Pan-Tumor Review of the Role of Poly(Adenosine Diphosphate Ribose) Polymerase Inhibitors

Ca-A Cancer Journal for Clinicians
Jennifer K Litton, Nicolas Sayegh, Chadi Hage Chehade   +2 more
exaly  

FGFR INHIBITOR COMBINATION THERAPIES

2022
SANTIAGO-WALKER ADEMI, MOY CHRISTOPHER
openaire   +1 more source

A Model for Decoding Resistance in Precision Oncology: Acquired Resistance to FGFR Inhibitors in Cholangiocarcinoma

Annals of Oncology
J M Cleary, J R Stone, E Wehrenberg-Klee
exaly  

ACYLAMINOPYRAZOLES AS FGFR INHIBITORS

2008
FOOTE KEVIN MICHAEL, THEOCLITOU MARIA-ELENA, THOMAS ANDREW PETER, BUTTAR DAVID   +3 more
openaire   +2 more sources

Methods of treating cancer with an FGFR inhibitor

2020
JI TAO, YELESWARAM KRISHNASWAMY
openaire   +2 more sources

Efficacy and Safety of Selective Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitors in FGFR-Altered Urothelial Carcinoma

Pharmacological Research
Yuxuan Song, Yiqing Du, Xing Luo
exaly  

SCREENING METHOD FOR FGFR INHIBITOR

2022
WANG YUGUANG, FENG ZHENHUA, WANG FEILAN, ZHANG NONG, WANG JING, XIAO WENJUAN   +5 more
openaire   +1 more source

TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS

2021
MCCAMMANT MATTHEW S, STYDUHAR EVAN, YAO WENQING   +2 more
openaire   +1 more source

FGFR AND EGFR INHIBITOR

2019
WANG YIKAI, ZHANG YANG, CHEN SHUHUI
openaire   +1 more source

HETEROCYCLIC COMPOUND USED AS FGFR INHIBITOR

2018
KONG NORMAN XIANGLONG, ZHOU CHAO, ZHENG ZHIXIANG   +2 more
openaire   +3 more sources